BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Luis Rodrigo. Ascites - Physiopathology, Treatment, Complications and Prognosis2017;  doi: 10.5772/intechopen.70232
2
Ioannis Bellos, Konstantinos Kontzoglou, Despina N Perrea. Predictors of tolvaptan short‐term response in patients with refractory ascites: A meta‐analysisJournal of Gastroenterology and Hepatology 2020; 35(2): 182 doi: 10.1111/jgh.14784
3
Hideto Kawaratani, Hiroshi Fukui, Kei Moriya, Ryuichi Noguchi, Tadashi Namisaki, Masakazu Uejima, Mitsuteru Kitade, Kosuke Takeda, Yasushi Okura, Kosuke Kaji, Norihisa Nishimura, Hiroaki Takaya, Yousuke Aihara, Yasuhiko Sawada, Shinya Sato, Kenichiro Seki, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Predictive parameter of tolvaptan effectiveness in cirrhotic ascitesHepatology Research 2017; 47(9): 854 doi: 10.1111/hepr.12826
4
Qi Ling, Haojiang Dai, Runzhou Zhuang, Tian Shen, Weilin Wang, Xiao Xu, Shusen Zheng. Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant RegistryScientific Reports 2017; 7(1) doi: 10.1038/srep42253
5
Theodosios D. Filippatos, George Liamis, Moses S. Elisaf. Ten pitfalls in the proper management of patients with hyponatremiaPostgraduate Medicine 2016; 128(5): 516 doi: 10.1080/00325481.2016.1186488
6
Yasuhiko Sawada, Makoto Shiraki, Motoh Iwasa, Atsushi Hiraoka, Hiroyuki Nakanishi, Yoshiyasu Karino, Tomoaki Nakajima, Hisamitsu Miyaaki, Takumi Kawaguchi, Hitoshi Yoshiji, Kiwamu Okita, Kazuhiko Koike. The effects of diuretic use and the presence of ascites on muscle cramps in patients with cirrhosis: a nationwide studyJournal of Gastroenterology 2020; 55(9): 868 doi: 10.1007/s00535-020-01694-8
7
Masayuki Miyazaki, Masayoshi Yada, Kosuke Tanaka, Takeshi Senjyu, Takeshi Goya, Kenta Motomura, Motoyuki Kohjima, Masaki Kato, Akihide Masumoto, Kazuhiro Kotoh. Efficacy of tolvaptan for the patients with advanced hepatocellular carcinomaWorld Journal of Gastroenterology 2017; 23(29): 5379-5385 doi: 10.3748/wjg.v23.i29.5379
8
Kazuto Tajiri, Yoshiharu Tokimitsu, Hiroyuki Ito, Yoshinari Atarashi, Kengo Kawai, Masami Minemura, Satoshi Yasumura, Terumi Takahara, Yukihiro Shimizu, Toshiro Sugiyama. Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced CirrhosisDigestive Diseases 2018; 36(4): 314 doi: 10.1159/000489258
9
E. Sbardella, A. M. Isidori, G. Arnaldi, M. Arosio, C. Barone, A. Benso, R. Berardi, G. Capasso, M. Caprio, F. Ceccato, G. Corona, S. Della Casa, L. De Nicola, M. Faustini-Fustini, E. Fiaccadori, L. Gesualdo, S. Gori, A. Lania, G. Mantovani, P. Menè, G. Parenti, C. Pinto, R. Pivonello, P. Razzore, G. Regolisti, C. Scaroni, F. Trepiccione, A. Lenzi, A. Peri. Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM)Journal of Endocrinological Investigation 2018; 41(1): 3 doi: 10.1007/s40618-017-0776-x
10
Carlos G. Musso, Rossina Juarez, Richard J. Glassock. Water, electrolyte, acid–base, and trace elements alterations in cirrhotic patientsInternational Urology and Nephrology 2018; 50(1): 81 doi: 10.1007/s11255-017-1614-y
11
Beata Kasztelan-Szczerbinska, Halina Cichoz-Lach. Refractory ascites—the contemporary view on pathogenesis and therapyPeerJ 2019; 7: e7855 doi: 10.7717/peerj.7855
12
Takefumi Mori, Yusuke Ohsaki, Ikuko Oba-Yabana, Sadayoshi Ito. Diuretic usage for protection against end-organ damage in liver cirrhosis and heart failureHepatology Research 2017; 47(1): 11 doi: 10.1111/hepr.12700
13
Hideto Kawaratani, Hiroshi Fukui, Hitoshi Yoshiji. Treatment for cirrhotic ascitesHepatology Research 2017; 47(2): 166 doi: 10.1111/hepr.12769